GNK

Genco is a pure-play drybulk shipper (Capesize/Ultramax/Supramax) whose FY2025 results show the cycle rolling over: revenue fell 19.1% to $342M, operating income collapsed 91.4% to $7.47M, and net income flipped to -$4.37M from +$76.4M. Operating cash flow dropped 74.9% to $31.9M, barely covering the $32.8M of dividends paid. Five-year history confirms this is a deeply cyclical name — earnings swung from +$182M (FY2021) to -$12.9M (FY2023) to +$76.4M (FY2024) back to a loss — so any single-year P/E or ROE figure is meaningless. At $24 the stock trades at ~1.16x stated book ($896M equity / 43.3M shares ≈ $20.70/share), which is a reasonable but not cheap entry for a shipping company at trough earnings.

The balance sheet remains the bull case: $55.5M cash, modest 0.27x liabilities/equity, and the company still ended FY2025 with $896M of equity despite a $569M accumulated deficit (legacy of prior restructuring). However, long-term debt jumped 130.1% to $189M in FY2025, and the MD&A explains why — management is leaning into the downcycle, agreeing to acquire two 2020-built Newcastlemax vessels for $145.5M (Nov 2025) and the Genco Courageous Capesize for $63.6M (Oct 2025), funded by drawdowns on the $600M and $500M revolvers. That is a defensible counter-cyclical capital allocation choice, but it adds leverage right as cash flow is contracting and ties the equity story to a rate recovery the filing itself does not promise.